Breakthrough treatment may end insulin use in type 2 diabetic patients
HQ Team October 15, 2024: A recent study presented at the United European Gastroenterology Week congress in Vienna unveiled a procedure that could
HQ Team October 15, 2024: A recent study presented at the United European Gastroenterology Week congress in Vienna unveiled a procedure that could
HQ Team October 15, 2024: Severe sepsis and septic shock are major causes of mortality in intensive care unit (ICU) patients. According to
HQ Team October 14, 2024: Children with aggressive blood cancer may soon have access to a new treatment, CAR T-cell therapy, targeting T-cell
H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug
Seventeen dangerous disease outbreaks, such as the Marburg virus and the latest strain of avian influenza this year, have increased the likelihood of
Microbiologists at Northwestern University have found toothbrushes and showerheads were teeming with diverse viruses not seen so far — and they don’t target
Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder
Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally,
HQ Team October 10, 2024: A recent study has raised concerns about the safety of topical benzoyl peroxide (BPO) products used for treating
HQ Team October 10, 2024: A study published in Nature Communications discusses a novel water-soluble prodrug technology called Sol-moiety, which enhances the oral bioavailability of